Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schiapparelli Farmaceutici is a historic Italian pharmaceutical company founded in 1824 by Settimio Schiapparelli in Turin. As one of the pioneers of the Italian chemical-pharmaceutical industry, the company evolved from a traditional pharmacy into a major industrial manufacturer of medicines, hygiene products, and chemical reagents. Throughout the 20th century, it was a prominent fixture in the Italian healthcare market before undergoing several corporate restructurings. The company's pharmaceutical assets were eventually acquired by Alfa Wassermann, which later merged to form Alfasigma. Today, the Schiapparelli 1824 brand remains active under the Alfasigma umbrella, focusing primarily on dermocosmetics, nutritional supplements, and over-the-counter healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schiapparelli Farmaceutici.